RESEARCH-USE BIOSIMILAR ANTIBODY
Romlusevimab
Monoclonal antibody · IgG1
Romlusevimab (BRII-198) is a neutralizing recombinant human IgG1 monoclonal antibody against the spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
TARGETSARS-CoV-2 Spike RBD
YMonoclonal antibody
CATALOGSC-BS-210
CATALOG NUMBERSC-BS-210
MOLECULAR WEIGHTApprox. 145.126 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Romlusevimab (BRII-198) is a neutralizing recombinant human IgG1 monoclonal antibody against the spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Romlusevimab is a recombinant research-use antibody directed against SARS-CoV-2 Spike RBD.